BRAF and metastatic melanoma: As relates to the targeted therapy use of BRAF inhibitors (if there is a BRAF mutation), this represents the standard care for metastatic melanoma both for melanomas associated with sun exposure or with lack of such association [18,30,37,48,136,176,191,196,225,226].